G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Director, Medical Affairs Research

Biology & BiotechConfirmed live in the last 24 hours
Full-timeFoster City, CA, USA

About the Job

Requirements

  • Candidates must have deep expertise in at least one of interventional Phase 4 research, observational or real-world evidence research, or implementation science; expertise in multiple areas is strongly preferred.
  • Candidates must demonstrate scientific credibility and thought leadership in oncology research.
  • Candidates must have experience serving as a major contributing author on manuscripts, abstracts, or scientific congress submissions.
  • Candidates must be able to translate complex evidence gaps into actionable research plans and collaborate across complex, matrixed organizations.
  • Candidates must have strong interpersonal, written, and verbal communication skills and be able to operate effectively in a global environment.
  • Candidates must demonstrate integrity, accountability, and commitment to compliant scientific exchange.
  • An advanced scientific or medical degree, such as a PhD, PharmD, MD, or MPH, is required.
  • Candidates must have a history of scientific publications and/or authorship in peer-reviewed journals within their primary methodological expertise.
  • Typically, candidates have 10 or more years of experience in oncology research, medical affairs, or related pharmaceutical or academic settings.
  • Candidates must have significant experience leading late-phase research, including Phase 4, collaborative, and Medical Affairs-led studies.
  • Candidates must have a strong understanding of regulatory, ethical, and compliance requirements governing Medical Affairs research activities.
  • Basic qualifications allow a bachelor's degree and twelve years of experience, a master's degree and ten years of experience, or a PhD, PharmD, MD, or MPH and eight years of experience.

Responsibilities

  • Lead Oncology Medical Affairs Research strategy aligned to Integrated Evidence Plans across assets and disease areas.
  • Provide scientific leadership for late-phase oncology research and select and apply appropriate methodologies based on evidence gaps.
  • Serve as Medical Affairs Study Lead for Gilead-sponsored and collaborative research studies.
  • Define research questions and guide protocol development for interventional, observational, and/or implementation science studies.
  • Oversee a portfolio of Oncology Medical Affairs Research studies, ensuring scientific rigor, operational feasibility, governance, and compliance.
  • Influence cross-functional partners across Development, Health Economics and Outcomes Research, Commercial, Safety, and external stakeholders.
  • Build and sustain external scientific partnerships with academic investigators, cooperative groups, data partners, and health systems.
  • Translate study findings into scientific communications such as abstracts, manuscripts, and presentations.
  • Provide mentorship and scientific leadership within Oncology Medical Affairs to strengthen research capability.
  • Ensure adherence to regulatory, legal, and business conduct standards governing Medical Affairs research.
  • Create an inclusive environment and embed the value of diverse teams in the way teams are managed.
  • Develop employee talent by understanding employees’ skills, experience, aspirations, and potential, and coaching them on current performance and future potential; ensure employees receive feedback and insight needed to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding the team accountable, removing barriers, and connecting the team to the broader ecosystem.

Desired Qualifications

  • Expertise in multiple methodological areas is strongly preferred.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs